
British scientists began testing in the Gambia for a new type of vaccine against malaria may be able one day to save the lives of millions, said Professor Adrian Hill of the University of Oxford to replace the vaccine test is the first of its kind.
In contrast to traditional vaccines, which is accustomed to body immune system to identify parasites that cause infection and elimination, the new vaccine will object to identify the infected cells.
He added: "The principle in the killing of cell parasite at the same time, and this would be the first vaccine designed to stimulate clearly this aspect of the immune system."
He pointed out that similar ideas could be used day to help in the prevention or treatment of other diseases as cancer or virus (HIV) that causes AIDS.
Hill added that the vaccine has already demonstrated the ability to reduce the spread of malaria from the experiments conducted in Britain, where people volunteered exposure to mosquito bites holder of infection.
But Gambia is the first test conducted on a large scale, and funded research institution Wellcome Trust, the largest charitable foundation world of medical research.
Hill said that malaria affects millions annually in tropical countries and kills between one million and two million children. There is currently an effective vaccine against a widespread use of this tropical disease which spreads through mosquitoes